CL2012000487A1 - Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales. - Google Patents
Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.Info
- Publication number
- CL2012000487A1 CL2012000487A1 CL2012000487A CL2012000487A CL2012000487A1 CL 2012000487 A1 CL2012000487 A1 CL 2012000487A1 CL 2012000487 A CL2012000487 A CL 2012000487A CL 2012000487 A CL2012000487 A CL 2012000487A CL 2012000487 A1 CL2012000487 A1 CL 2012000487A1
- Authority
- CL
- Chile
- Prior art keywords
- disorders
- treat
- composition
- bifidobacterium longum
- prevent functional
- Prior art date
Links
- 241001608472 Bifidobacterium longum Species 0.000 title 1
- 229940009291 bifidobacterium longum Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09168590.9A EP2289527B1 (en) | 2009-08-25 | 2009-08-25 | Bifidobacterium longum and functional GI disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012000487A1 true CL2012000487A1 (es) | 2012-08-31 |
Family
ID=41508246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012000487A CL2012000487A1 (es) | 2009-08-25 | 2012-02-24 | Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales. |
Country Status (17)
Country | Link |
---|---|
US (3) | US10028981B2 (es) |
EP (2) | EP2289527B1 (es) |
JP (4) | JP2013503130A (es) |
CN (2) | CN106072658A (es) |
AU (1) | AU2010288546B2 (es) |
BR (1) | BR112012004046B1 (es) |
CA (1) | CA2772163C (es) |
CL (1) | CL2012000487A1 (es) |
DK (1) | DK2289527T3 (es) |
ES (1) | ES2664828T3 (es) |
IN (1) | IN2012DN01638A (es) |
MX (1) | MX2012002402A (es) |
RU (1) | RU2012111253A (es) |
SG (1) | SG178499A1 (es) |
TR (1) | TR201807143T4 (es) |
WO (1) | WO2011023689A1 (es) |
ZA (1) | ZA201202155B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2110028A1 (en) | 2008-04-15 | 2009-10-21 | Nestec S.A. | Bifidobacterium longum and hippocampal BDNF expression |
TR201807143T4 (tr) | 2009-08-25 | 2018-06-21 | Nestec Sa | Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar. |
EP2452576A1 (en) * | 2010-11-11 | 2012-05-16 | Nestec S.A. | Extruded non-replicating probiotic micro-organisms and their health benefits |
WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
US11179427B2 (en) | 2013-01-21 | 2021-11-23 | Eth Zurich | Baby food composition comprising viable propionic acid-producing bacteria |
GB2535034A (en) | 2013-07-21 | 2016-08-10 | Whole Biome Inc | Methods and systems for microbiome characterization, monitoring and treatment |
US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
CN113730442A (zh) | 2014-10-31 | 2021-12-03 | 潘德勒姆治疗公司 | 与病症的微生物治疗和诊断有关的方法和组合物 |
WO2016183535A1 (en) | 2015-05-14 | 2016-11-17 | University Of Puerto Rico | Methods for restoring microbiota of newborns |
EP3307290B1 (en) | 2015-06-11 | 2020-04-15 | Société des Produits Nestlé S.A. | Dietary supplement |
CA2994347A1 (en) * | 2015-08-31 | 2017-03-09 | Nestec S.A. | Methods and compositions using bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances |
JP2018525390A (ja) * | 2015-08-31 | 2018-09-06 | ネステク ソシエテ アノニム | 抑うつ症状を治療又は予防するための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物 |
CN107980002A (zh) * | 2015-08-31 | 2018-05-01 | 雀巢产品技术援助有限公司 | 使用长双岐杆菌优化母乳喂养的方法和组合物 |
PL3368046T3 (pl) | 2015-10-28 | 2022-11-28 | Glycom A/S | Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania |
US10780103B2 (en) | 2015-10-28 | 2020-09-22 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
JP6353478B2 (ja) * | 2016-03-28 | 2018-07-04 | 日清食品ホールディングス株式会社 | セロトニン分泌促進能力を有するビフィズス菌 |
CN107050062A (zh) * | 2016-11-08 | 2017-08-18 | 江西益盟科技有限公司 | 治疗便秘的乳酸菌组合物及其制备方法 |
CN106579414A (zh) * | 2016-12-26 | 2017-04-26 | 北京康比特体育科技股份有限公司 | 一种缓解运动性腹泻的组合物 |
US11529381B2 (en) | 2017-02-28 | 2022-12-20 | Precisionbiotics Group Limited | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
EP3589726A1 (en) | 2017-02-28 | 2020-01-08 | Alimentary Health Limited | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
WO2018202657A1 (en) * | 2017-05-05 | 2018-11-08 | Nestec S.A. | Treatment of infant colic |
CA3073838A1 (en) | 2017-08-30 | 2019-03-07 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
US20190298783A1 (en) | 2018-03-28 | 2019-10-03 | Morinaga Milk Industry Co., Ltd. | Composition for relieving stress, pharmaceutical composition and food and drink composition and method for relieving stress using the composition for relieving stress |
WO2021001367A1 (en) * | 2019-07-01 | 2021-01-07 | Société des Produits Nestlé S.A. | Serpin production |
JP2021014422A (ja) * | 2019-07-11 | 2021-02-12 | 日清ファルマ株式会社 | 便性改善剤 |
JP2021014421A (ja) * | 2019-07-11 | 2021-02-12 | 日清ファルマ株式会社 | Qol改善剤 |
CN111187734A (zh) * | 2019-12-25 | 2020-05-22 | 生合生物科技(扬州)有限公司 | 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用 |
JP2023526288A (ja) * | 2020-05-20 | 2023-06-21 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | ビフィドバクテリウム・ロンガムによる不溶性繊維の発酵性及び短鎖脂肪酸産生の改善 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH637297A5 (fr) | 1978-12-05 | 1983-07-29 | Nestle Sa | Microbille comprenant un microorganisme et son procede de fabrication. |
ID29150A (id) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
DE10008279A1 (de) * | 2000-02-23 | 2001-08-30 | Meggle Gmbh | Milchzucker enthaltende Zusammensetzung |
US6592863B2 (en) * | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
PE20030284A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de bifidobacterium |
US7033629B2 (en) * | 2001-08-31 | 2006-04-25 | Nutricopia Inc. | Nutritional frozen dessert and methods of manufacture |
EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
AU2003303894A1 (en) * | 2003-01-30 | 2004-08-30 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
JP2004262773A (ja) * | 2003-02-17 | 2004-09-24 | Ryoshoku Kenkyukai | 免疫機能改善を目的としたビフィズス菌製剤 |
US20040265279A1 (en) | 2003-05-08 | 2004-12-30 | Timothy Dinan | Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity |
ES2326481T3 (es) * | 2003-06-23 | 2009-10-13 | Nestec S.A. | Formula para recien nacidos o formula de continuacion. |
US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
US8134942B2 (en) * | 2005-08-24 | 2012-03-13 | Avaak, Inc. | Communication protocol for low-power network applications and a network of sensors using the same |
EP1947962B1 (en) * | 2005-11-14 | 2010-10-06 | Unilever N.V. | Edible product containing ginseng polysaccharides and beneficial bacteria |
JP2007169200A (ja) * | 2005-12-21 | 2007-07-05 | Morinaga Milk Ind Co Ltd | インフルエンザ感染予防のための医薬及び飲食品 |
MX2008010422A (es) | 2006-02-15 | 2008-10-27 | Nestec Sa | Uso de bifidobacterium longum para la prevencion y tratamiento de inflamacion. |
BRPI0708689A2 (pt) | 2006-03-07 | 2011-06-07 | Nestec Sa | mistura simbiótica |
EP1961308A1 (en) * | 2007-02-21 | 2008-08-27 | Nestec S.A. | Nutritionally balanced frozen dessert |
EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
EP1974735A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Reduction of risk of diarrhoea |
US9113641B2 (en) * | 2007-12-06 | 2015-08-25 | Arla Foods Amba | Probiotic bacteria and regulation of fat storage |
CA2709579A1 (en) * | 2007-12-17 | 2009-06-25 | University Of Florida Research Foundation, Inc. | Materials and methods for treatment of pathological ocular vascular proliferation |
EP2110028A1 (en) | 2008-04-15 | 2009-10-21 | Nestec S.A. | Bifidobacterium longum and hippocampal BDNF expression |
WO2010008272A1 (en) * | 2008-07-15 | 2010-01-21 | N.V. Nutricia | Treatment of gut motility disorders |
TR201807143T4 (tr) | 2009-08-25 | 2018-06-21 | Nestec Sa | Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar. |
CN112074193A (zh) * | 2018-01-29 | 2020-12-11 | 精密生物集团有限公司 | 一种用于预防和治疗肠易激综合征的组合产品 |
-
2009
- 2009-08-25 TR TR2018/07143T patent/TR201807143T4/tr unknown
- 2009-08-25 EP EP09168590.9A patent/EP2289527B1/en not_active Revoked
- 2009-08-25 ES ES09168590.9T patent/ES2664828T3/es active Active
- 2009-08-25 DK DK09168590.9T patent/DK2289527T3/en active
-
2010
- 2010-08-24 AU AU2010288546A patent/AU2010288546B2/en active Active
- 2010-08-24 RU RU2012111253/15A patent/RU2012111253A/ru not_active Application Discontinuation
- 2010-08-24 CA CA2772163A patent/CA2772163C/en active Active
- 2010-08-24 BR BR112012004046-4A patent/BR112012004046B1/pt active IP Right Grant
- 2010-08-24 IN IN1638DEN2012 patent/IN2012DN01638A/en unknown
- 2010-08-24 US US13/391,343 patent/US10028981B2/en active Active
- 2010-08-24 MX MX2012002402A patent/MX2012002402A/es not_active Application Discontinuation
- 2010-08-24 CN CN201610417206.3A patent/CN106072658A/zh active Pending
- 2010-08-24 CN CN2010800480174A patent/CN102573863A/zh active Pending
- 2010-08-24 JP JP2012526036A patent/JP2013503130A/ja active Pending
- 2010-08-24 SG SG2012011474A patent/SG178499A1/en unknown
- 2010-08-24 EP EP10747451A patent/EP2470188A1/en active Pending
- 2010-08-24 WO PCT/EP2010/062320 patent/WO2011023689A1/en active Application Filing
-
2012
- 2012-02-24 CL CL2012000487A patent/CL2012000487A1/es unknown
- 2012-03-23 ZA ZA2012/02155A patent/ZA201202155B/en unknown
-
2015
- 2015-11-09 JP JP2015219799A patent/JP2016074682A/ja active Pending
-
2017
- 2017-08-18 JP JP2017158082A patent/JP7096652B6/ja active Active
-
2018
- 2018-06-29 US US16/023,503 patent/US11452745B2/en active Active
-
2020
- 2020-06-18 JP JP2020105621A patent/JP2020183385A/ja active Pending
-
2022
- 2022-04-27 US US17/730,891 patent/US11957720B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2289527A1 (en) | 2011-03-02 |
SG178499A1 (en) | 2012-04-27 |
JP2016074682A (ja) | 2016-05-12 |
CN102573863A (zh) | 2012-07-11 |
BR112012004046B1 (pt) | 2021-02-17 |
US20190134104A1 (en) | 2019-05-09 |
US20120230956A1 (en) | 2012-09-13 |
US11452745B2 (en) | 2022-09-27 |
ES2664828T3 (es) | 2018-04-23 |
JP2013503130A (ja) | 2013-01-31 |
BR112012004046A2 (pt) | 2017-05-30 |
DK2289527T3 (en) | 2018-04-23 |
RU2012111253A (ru) | 2013-10-10 |
CN106072658A (zh) | 2016-11-09 |
CA2772163C (en) | 2017-11-07 |
WO2011023689A1 (en) | 2011-03-03 |
US10028981B2 (en) | 2018-07-24 |
TR201807143T4 (tr) | 2018-06-21 |
US20220280576A1 (en) | 2022-09-08 |
AU2010288546B2 (en) | 2015-08-20 |
EP2470188A1 (en) | 2012-07-04 |
US11957720B2 (en) | 2024-04-16 |
AU2010288546A1 (en) | 2012-03-22 |
ZA201202155B (en) | 2014-09-25 |
JP2020183385A (ja) | 2020-11-12 |
CA2772163A1 (en) | 2011-03-03 |
EP2289527B1 (en) | 2018-02-21 |
JP2018048112A (ja) | 2018-03-29 |
JP7096652B6 (ja) | 2022-08-01 |
IN2012DN01638A (es) | 2015-06-05 |
MX2012002402A (es) | 2012-04-02 |
JP7096652B2 (ja) | 2022-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2012000487A1 (es) | Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales. | |
SMT201500280B (it) | Nuove composizioni per prevenire e/o trattare disturbi da accumulo lisosomiale | |
CL2009000905A1 (es) | Composicion comestible que comprende bifidobacterium longum atcc baa-999; y su uso para tratar o prevenir la ansiedad y/o desordenes relacionados con ansiedad. | |
BR112012005533A2 (pt) | material não viável derivado de probiótijco para prevenção e tratamento de alegria | |
BRPI0911757A2 (pt) | composiÇÕes e mÉtodos para tratar distérbios digestivos. | |
BR112012004149A2 (pt) | terapia de combinação com composições de nanopartículas de taxano e inibidores de hedgehog | |
BR112012001912A2 (pt) | Composições nutritivas que compreendem fibra e probióticos | |
BRPI1006147A2 (pt) | composições que compreendem componentes probióticos e prebióticos e sais mineirais, com lactoferrina | |
BRPI0922486A2 (pt) | microcápsulas e suas respectivas utilizações | |
DOP2012000115A (es) | Metodos para preparar y usar composiciones que comprenden flavonoides | |
BRPI0815407A2 (pt) | Composições e métodos para controlar nematódeos | |
FI20095836A (fi) | Probioottinen valmiste koirien maha- ja suolistohäiriöiden ennaltaehkäisyyn tai hoitoon | |
BRPI0915476A2 (pt) | dispositivo para tratar problemas respiratórios | |
BRPI1013065A2 (pt) | artigo para fumar com elemento de restrição de fluxo aperfeiçoado | |
BR112012004979A2 (pt) | composições para o tratamento de semente e métodos | |
BRPI0911612A2 (pt) | composições e métodos para o tratamento da esclerose múltipla. | |
FI20096058A0 (fi) | Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä | |
BRPI1013361A2 (pt) | método para evitar e tratar hipermeabilidade. | |
BRPI0916043A2 (pt) | composição farmacêutica e alimento funcional para prevenir ou tratar câncer | |
BR112014011724A2 (pt) | composição de barra de sabão e barra de sabão | |
BRPI0908334A2 (pt) | kit, composição, produto ou medicamento para tratar comprometimento cognitivo | |
BRPI0722183A2 (pt) | Composições farmacêuticas para tratar depressão e ansiedade | |
BR112012006437A2 (pt) | composições e métodos para tratamento do diabetes e outros distúrbios | |
CL2013001313A1 (es) | Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales | |
HK1116703A1 (en) | One kind of chinese medicine which treats acute and chronic enterogastritis |